Description
LXS-196 is a selective inhibitor of protein kinase C (PKC). It is being investigated as a treatment for metastatic uveal melanoma, and may exhibit antitumor effects in other advanced tumors characterized by the overexpression of PKC.
LXS-196
Product ID L943721
Cas No. 1874276-76-2
Purity ≥98%
| Product Unit Size | Cost | Quantity | Stock |
|---|
Product Info
| Cas No. | 1874276-76-2 |
|---|---|
| Purity | ≥98% |
| Formula | C22H23F3N8O |
| Formula Wt. | 472.48 |
| Chemical Name | LXS-196 |
| IUPAC Name | 3-Amino-N-[3-(4-amino-4-methyl-1-piperidinyl)-2-pyridinyl]-6-[3-(trifluoromethyl)-2-pyridinyl]-2-pyrazinecarboxamide |
| Synonym | LXS 196, LXS196, NVP-LXS196, Darovasertib |
Shipping and Storage
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
Downloads
| MSDS | |
|---|---|
| Info Sheet |